A drug that has already been shown to be effective in fighting breast cancer could help men win the war on prostate cancer, according to a flagship London study.
The drug, called talazoparib, is taken as a daily pill and is already used successfully by breast cancer patients, according to the Sunday Times.
The report, citing research from the London Cancer Research Institute and the Royal Marsden NHS Foundation Trust, said phase two trials of the drug stopped the progression of advanced prostate cancer by an average of 5 , 6 months, twice as long as possible with existing treatments. .
“Talazoparib is now among a handful of precision medicines that have been shown to be safe and effective in controlling advanced prostate cancer,” said Matthew Hobbs, research director at Prostate Cancer UK. “We need to promote progress in this area as quickly as possible.”
The treatment was found to be especially effective for men with a mutated BRCA gene who are genetically predisposed to prostate cancer, similar to the mutation carried by Angelina Jolie, which increased their risk of ovarian and ovarian cancer. mama.
The oncology journal Lancet has published the results of the study this month.